Sign in and upgrade to a paid plan to export board meetings as CSV.

Alkem Laboratories Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: ALKEM BSE: 539523

About Alkem Laboratories Limited

Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets.

Source: Wikipedia

Key facts

BSE symbol539523
NSE symbolALKEM
ISININE540L01014
CINL00305MH1973PLC174201
Listing date23 Dec 2015
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorMANISH GHIA & ASSOCIATES, PRACTICING COMPANY SECRETARIES (MANNISH L GHIA)
Registered officeAlkem House, Senapati Bapat Marg, Lower Parel, Mumbai- 400013
Registrar & transfer agentMUFG Intime India Private Limited C-101, 247 Park, Lal Bahadur Shastri Marg, Gandhi Nagar, Vikhroli West, Mumbai ��� 400 083

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23Mar 22
Total income (before exceptional items)——10,054†9,321†9,030†
Net profit2,2822,2811,7471,1341,541†

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
Basudeo N. SinghExecutive DirectorJune 30, 2026
Madhurima SinghExecutive DirectorJune 30, 2026
Mritunjay Kumar SinghExecutive DirectorJune 30, 2026
Sandeep SinghExecutive DirectorJune 30, 2026
Sarvesh SinghExecutive DirectorJune 30, 2026
Srinivas SinghExecutive DirectorJune 30, 2026
Diwakar GuptaIndependent DirectorJune 30, 2026
Laxmana Ranjal ShenoyIndependent DirectorJune 30, 2026
Narendra AnejaIndependent DirectorJune 30, 2026
Neela BhattacherjeeIndependent DirectorJune 30, 2026
Rajeev KherIndependent DirectorJune 30, 2026
Sujjain TalwarIndependent DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.